Enclomimed 25

Description

Here’s a detailed description of Enclomimed 25 (Enclomiphene citrate) for scientific research purposes:

---

Product Overview:

Enclomimed 25 is a compound classified as a selective modulator of the non-steroidal receptor. Research compound for laboratory use only. Not for human consumption.

Development and Research :

Evolving from the well-established Clomiphene, Enclomiphene citrate is a subject of ongoing scientific investigation. In scientific studies, Enclomiphene citrate has been observed to bind to receptors.

Manufacturing Quality:

Deus Medical assures that Enclomimed 25 is manufactured in high-standard pharmaceutical facilities located in India, and is not sourced from repackaged powders from China. All products are subjected to rigorous testing and certification by European third parties, ensuring compliance with distribution standards across Europe. Enclomimed 25 is available in tablet form, securely packaged in practical blisters.

Information for Scientific Research:

Enclomimed 25 contains Enclomiphene citrate at a dosage of 25mg per tablet.

---

This overview provides information relevant to scientific research.

1. Kaminetsky, J., Werner, M., Fontenot, G., & Wiehle, R. D. (2013). Oral enclomiphene citrate stimulates the endogenous production of and sperm counts in men with low : comparison with gel. Journal of Medicine, 10(6), 1628-1635. Link

2. Wiehle, R., Cunningham, G. R., Pitteloud, N., Wike, J., Hsu, K., Fontenot, G. K., & Rosenthal, D. M. (2014). restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics. BJU international, 114(5), 663-671. Link

3. Kohn, T. P., Louis, M. R., Pickett, S. M., Lindgren, M. C., Kohn, J. R., Pastuszak, A. W., & Lipshultz, L. I. (2018). Age and duration of predict time to return of sperm count after human chorionic gonadotropin. and sterility, 109(1), 103-109. Link

4. Watson, L. M., & Aronica, S. M. (2018). A meta-analysis of clomiphene citrate administration in men with idiopathic oligozoospermia. and sterility. Link

5. Zitzmann M, Nieschlag E. (2003). Hormone substitution in male hypogonadism. Molecular and cellular endocrinology, 117, 75-78. Link

6. Kolodziej, A., Kopeć, W., Mędraś, M. (2005). The role of selective receptor modulator (SERM) in men with idiopathic oligozoospermia. Endokrynologia polska,